A protein used by doctors to indicate a patient’s risk of coronary heart disease may have drug developers barking up the wrong treatment tree, according a new study. Their research suggests that C-reactive protein, an enticing target for scientists working on new treatments for coronary heart disease, may not have a role in causing the disease, even though it is a predictive marker.